
What Clinicians Want to Know About the Management of Relapsed/Refractory Mantle Cell Lymphoma
Hematologic Oncology Update
00:00
Toxicity and Comparative Analysis of BTK Inhibitors in Mantle Cell Lymphoma
This chapter discusses the toxicity of pertubutinib and covalent btk inhibitors in the treatment of Mantle cell lymphoma, including the common toxicities associated with btk inhibitors and the ongoing study comparing pertubutinib with covalent btk inhibitors to determine comparative toxicity.
Transcript
Play full episode